Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma

The gut microbiome has been explored extensively for its importance in the modulation of systemic inflammation and immune response; in contrast, the intratumoral microbiome is less studied for its influence on immunity in cancer. Given the established correlation between intratumoral lymphocyte infiltration and patient survival in cases of solid tumors, it was pertinent to explore the extrinsic factor influencing immune cell infiltration in the tumor. ABSTRACT Characterization of the oral microbiota profile through various studies has shown an association between the microbiome and oral cancer; however, stage-specific determinants of dynamic changes in microbial communities of oral cancer remain elusive. Additionally, the influence of the intratumoral microbiota on the intratumoral immune system remains largely unexplored. Therefore, this study aims to stratify microbial abundance in the early-onset and subsequent stages of oral cancer and analyze their influence on clinical-pathological and immunological features. The microbiome composition of tissue biopsy samples was identified using 16S rRNA amplicon sequencing, while intratumoral and systemic immune profiling was done with flow cytometry and immunohistochemistry-based analysis. The bacterial composition differed significantly among precancer, early cancer, and late cancer stages with the enrichment of genera Capnocytophaga, Fusobacterium, and Treponema in the cancer group, while Streptococcus and Rothia were enriched in the precancer group. Late cancer stages were significantly associated with Capnocytophaga with high predicting accuracy, while Fusobacterium was associated with early stages of cancer. A dense intermicrobial and microbiome-immune network was observed in the precancer group. At the cellular level, intratumoral immune cell infiltration of B cells and T cells (CD4+ and CD8+) was observed with enrichment of the effector memory phenotype. Naive and effector subsets of tumor-infiltrating lymphocytes (TILs) and related gene expression were found to be distinctly associated with bacterial communities; most importantly, highly abundant bacterial genera of the tumor microenvironment were either negatively correlated or not associated with the effector lymphocytes, which led to the conclusion that the tumor microenvironment favors an immunosuppressive and nonimmunogenic microbiota. IMPORTANCE The gut microbiome has been explored extensively for its importance in the modulation of systemic inflammation and immune response; in contrast, the intratumoral microbiome is less studied for its influence on immunity in cancer. Given the established correlation between intratumoral lymphocyte infiltration and patient survival in cases of solid tumors, it was pertinent to explore the extrinsic factor influencing immune cell infiltration in the tumor. Modulation of intratumoral microbiota could have a beneficial effect on the antitumor immune response. This study stratifies the microbial profile of oral squamous cell carcinoma starting from precancer to late-stage cancer and provides evidence for their immunomodulatory role in the tumor microenvironment. Our results suggest combining microbiome study with immunological signatures of tumors for their prognostic and diagnostic application.

[1]  Hongzhong Li,et al.  Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies , 2022, Journal of Hematology & Oncology.

[2]  D. Costea,et al.  Analysis of Salivary Mycobiome in a Cohort of Oral Squamous Cell Carcinoma Patients From Sudan Identifies Higher Salivary Carriage of Malassezia as an Independent and Favorable Predictor of Overall Survival , 2021, Frontiers in Cellular and Infection Microbiology.

[3]  G. Nair,et al.  The Vaginal Microbial Signatures of Preterm Birth Delivery in Indian Women , 2021, Frontiers in Cellular and Infection Microbiology.

[4]  M. Sohrabi,et al.  Role of microbiota-derived short-chain fatty acids in cancer development and prevention. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  C. Eng,et al.  Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer , 2021, Genome medicine.

[6]  J. Wargo,et al.  Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect , 2021, Cancer Immunology Research.

[7]  J. Hasty,et al.  The microbiome and human cancer , 2021, Science.

[8]  Yanbing Wang,et al.  The role of Short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis. , 2021, Pharmacological research.

[9]  S. Morré,et al.  The Association Between Vaginal Microbiota Dysbiosis, Bacterial Vaginosis, and Aerobic Vaginitis, and Adverse Pregnancy Outcomes of Women Living in Sub-Saharan Africa: A Systematic Review , 2020, Frontiers in Public Health.

[10]  Lanjuan Li,et al.  The Intestinal Microbiota and Colorectal Cancer , 2020, Frontiers in Immunology.

[11]  S. Nathan,et al.  Advantages and Limitations of 16S rRNA Next-Generation Sequencing for Pathogen Identification in the Diagnostic Microbiology Laboratory: Perspectives from a Middle-Income Country , 2020, Diagnostics.

[12]  C. Huang,et al.  Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic Review , 2020, Frontiers in Oncology.

[13]  Hilal Bashir,et al.  Emerging role of microbiota in immunomodulation and cancer immunotherapy. , 2020, Seminars in cancer biology.

[14]  Charles Nkufi Tango,et al.  Taxonomic and Functional Differences in Cervical Microbiome Associated with Cervical Cancer Development , 2020, Scientific Reports.

[15]  Noam Shental,et al.  The human tumor microbiome is composed of tumor type–specific intracellular bacteria , 2020, Science.

[16]  Ligong Chen,et al.  Memory T cells: strategies for optimizing tumor immunotherapy , 2020, Protein & Cell.

[17]  H. Harmsen,et al.  Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients , 2020, Journal of clinical medicine.

[18]  D. Longley,et al.  Fusobacterium nucleatum in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-analysis , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[19]  U. Gophna,et al.  Fecal microbiome signatures of pancreatic cancer patients , 2019, Scientific Reports.

[20]  Hongwei Li,et al.  Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer , 2019, International journal of biological sciences.

[21]  F. Greten,et al.  Inflammation and Cancer: Triggers, Mechanisms, and Consequences. , 2019, Immunity.

[22]  W. Borgnakke,et al.  The Microbiome of Oral Squamous Cell Carcinomas: a Functional Perspective , 2019, Current Oral Health Reports.

[23]  Guangxiu Liu,et al.  Relationship between intestinal microbial dysbiosis and primary liver cancer. , 2019, Hepatobiliary & pancreatic diseases international : HBPD INT.

[24]  Yong Zhou,et al.  Salivary Microbial Dysbiosis is Associated with Systemic Inflammatory Markers and Predicted Oral Metabolites in Non-Small Cell Lung Cancer Patients , 2019, Journal of Cancer.

[25]  K. Faber,et al.  Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases , 2019, Front. Immunol..

[26]  Rob Knight,et al.  Contamination in Low Microbial Biomass Microbiome Studies: Issues and Recommendations. , 2019, Trends in microbiology.

[27]  H. Nishikawa,et al.  Regulatory T cells in cancer immunosuppression — implications for anticancer therapy , 2019, Nature Reviews Clinical Oncology.

[28]  P. Chaturvedi,et al.  Role of Poor Oral Hygiene in Causation of Oral Cancer—a Review of Literature , 2018, Indian Journal of Surgical Oncology.

[29]  M. Morrison,et al.  The Performance of an Oral Microbiome Biomarker Panel in Predicting Oral Cavity and Oropharyngeal Cancers , 2018, Front. Cell. Infect. Microbiol..

[30]  T. Meirson,et al.  Oral inflammation promotes oral squamous cell carcinoma invasion , 2018, Oncotarget.

[31]  C. Liao,et al.  Oral Microbiota Community Dynamics Associated With Oral Squamous Cell Carcinoma Staging , 2018, Front. Microbiol..

[32]  S. Pushalkar,et al.  The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. , 2018, Cancer discovery.

[33]  R. Hayes,et al.  Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer , 2018, JAMA oncology.

[34]  J. Slotta-Huspenina,et al.  Gut microbiota modulate T cell trafficking into human colorectal cancer , 2018, Gut.

[35]  R. Isaacson,et al.  Deciphering Diversity Indices for a Better Understanding of Microbial Communities. , 2017, Journal of microbiology and biotechnology.

[36]  Timothy L. Tickle,et al.  Alterations in oral bacterial communities are associated with risk factors for oral and oropharyngeal cancer , 2017, Scientific Reports.

[37]  Hsien-Da Huang,et al.  Bacterial alterations in salivary microbiota and their association in oral cancer , 2017, Scientific Reports.

[38]  D. Relman,et al.  Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data , 2017, Microbiome.

[39]  Chenping Zhang,et al.  Variations in oral microbiota associated with oral cancer , 2017, Scientific Reports.

[40]  Shan Jiang,et al.  Human papillomavirus and oral squamous cell carcinoma: A review of HPV-positive oral squamous cell carcinoma and possible strategies for future. , 2017, Current problems in cancer.

[41]  O. Dizdar,et al.  Increased cancer risk in patients with periodontitis , 2017, Current medical research and opinion.

[42]  M. Redinbo,et al.  The role of the microbiome in cancer development and therapy , 2017, CA: a cancer journal for clinicians.

[43]  H. Saluja,et al.  The prevalence of squamous cell carcinoma in different sites of oral cavity at our Rural Health Care Centre in Loni, Maharashtra – a retrospective 10-year study , 2017, Contemporary oncology.

[44]  J. Madrigal,et al.  B cell regulation in cancer and anti-tumor immunity , 2017, Cellular &Molecular Immunology.

[45]  Tsute Chen,et al.  Inflammatory bacteriome featuring Fusobacterium nucleatum and Pseudomonas aeruginosa identified in association with oral squamous cell carcinoma , 2017, Scientific Reports.

[46]  Xiang Gao,et al.  A Bayesian taxonomic classification method for 16S rRNA gene sequences with improved species-level accuracy , 2017, BMC Bioinformatics.

[47]  D. Missé,et al.  Infections and cancer: the “fifty shades of immunity” hypothesis , 2017, BMC Cancer.

[48]  B. Burkey,et al.  Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas , 2017, Genome Medicine.

[49]  R. Vivek,et al.  Linkages between oral commensal bacteria and atherosclerotic plaques in coronary artery disease patients , 2016, npj Biofilms and Microbiomes.

[50]  D. Sidransky,et al.  16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment , 2016, Oncotarget.

[51]  N. Johnson,et al.  Emerging role of bacteria in oral carcinogenesis: a review with special reference to perio-pathogenic bacteria , 2016, Journal of oral microbiology.

[52]  Bin Shang,et al.  Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis , 2015, Scientific Reports.

[53]  Michael Elkin,et al.  Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model , 2015, Oncotarget.

[54]  Koichi Hirata,et al.  Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis , 2015, Oncotarget.

[55]  Bernard M. Corfe,et al.  Dysbiosis of the gut microbiota in disease , 2015, Microbial ecology in health and disease.

[56]  Shunsuke Takahashi,et al.  Development of a Prokaryotic Universal Primer for Simultaneous Analysis of Bacteria and Archaea Using Next-Generation Sequencing , 2014, PloS one.

[57]  Adam B. Olshen,et al.  Changes in Abundance of Oral Microbiota Associated with Oral Cancer , 2014, PloS one.

[58]  M. Hallek,et al.  Characterization of tumor-associated B-cell subsets in patients with colorectal cancer , 2014, Oncotarget.

[59]  Jizhong Zhou,et al.  Phylogenetic and functional gene structure shifts of the oral microbiomes in periodontitis patients , 2014, The ISME Journal.

[60]  Shashikanth Hegde,et al.  Poor periodontal health: A cancer risk? , 2013, Journal of Indian Society of Periodontology.

[61]  Yong-Deok Kim,et al.  The impact factors on 5-year survival rate in patients operated with oral cancer , 2013, Journal of the Korean Association of Oral and Maxillofacial Surgeons.

[62]  Susan Holmes,et al.  phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.

[63]  Y. Ko,et al.  The neoplastic impact of tobacco‐free betel‐quid on the histological type and the anatomical site of aerodigestive tract cancers , 2012, International journal of cancer.

[64]  Bhuvanesh Singh,et al.  Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma , 2012, BMC Microbiology.

[65]  P. Chaturvedi,et al.  Arecanut as an emerging etiology of oral cancers in India , 2012, Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology.

[66]  S. Hiremath,et al.  Oral Cancer in India: An Epidemiologic and Clinical Review , 2012, Journal of Community Health.

[67]  Rob Knight,et al.  Using QIIME to Analyze 16S rRNA Gene Sequences from Microbial Communities , 2011, Current protocols in bioinformatics.

[68]  N. Johnson,et al.  Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. , 2011, Periodontology 2000.

[69]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[70]  A. Kruse,et al.  Oral squamous cell carcinoma in non-smoking and non-drinking patients , 2010, Head & neck oncology.

[71]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[72]  L. Turek,et al.  Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers , 2010, Cancer Causes & Control.

[73]  Marina Mohd Bakri,et al.  Revisiting the association between candidal infection and carcinoma, particularly oral squamous cell carcinoma , 2010, Journal of oral microbiology.

[74]  Ning Ma,et al.  BLAST+: architecture and applications , 2009, BMC Bioinformatics.

[75]  Zlatko Trajanoski,et al.  In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[76]  W. Wade,et al.  A molecular analysis of the bacteria present within oral squamous cell carcinoma. , 2007, Journal of medical microbiology.

[77]  C. Parish,et al.  Th2-mediated anti-tumour immunity: friend or foe? , 2007, Tissue antigens.

[78]  Eoin L. Brodie,et al.  Greengenes: Chimera-checked 16S rRNA gene database and workbench compatible in ARB , 2006 .

[79]  M. Posner,et al.  The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects , 2005, Journal of Translational Medicine.

[80]  S. Kimura,et al.  Streptococcus anginosus infection in oral cancer and its infection route. , 2005, Oral diseases.

[81]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[82]  M. Terada,et al.  Different frequencies of Streptococcus anginosus infection in oral cancer and esophageal cancer , 2003, Cancer science.

[83]  Laurie H Glimcher,et al.  A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment , 2000, Cell.

[84]  Y. Ko,et al.  Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. , 1995, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[85]  T. Aune,et al.  Inhibition of tumor cell growth by interferon-gamma is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide. , 1989, The Journal of clinical investigation.

[86]  J. T. Curtis,et al.  An Ordination of the Upland Forest Communities of Southern Wisconsin , 1957 .

[87]  B. Sampaio-Maia,et al.  The Oral Microbiome in Health and Its Implication in Oral and Systemic Diseases. , 2016, Advances in applied microbiology.

[88]  T. Wiele,et al.  Microbiota and their role in the pathogenesis of oral mucositis. , 2015, Oral diseases.

[89]  Robert C. Edgar,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2001 .

[90]  Cancer.Net. , 2008, Journal of oncology practice.

[91]  Christopher B Wilson,et al.  Regulation of interferon-gamma during innate and adaptive immune responses. , 2007, Advances in immunology.

[92]  A. Chao,et al.  Nonparametric estimation of Shannon’s index of diversity when there are unseen species in sample , 2004, Environmental and Ecological Statistics.